Development and supply of safe and effective vaccine for global public health



Euvichol-Plus®is an oral cholera vaccine for the prevention of cholera occurring mainly in Africa and Asia. Euvichol-Plus® has been supplied to low and middle income countries which are cholera endemic or regularlyexperience the cholera outbreak through the WHO Stockpile funded by Global Alliance for Vaccines and Immunizations (GAVI) after receiving WHO PQ certification. Euvichol-Plus® can be easily administered without aseparate buffer and supplied at affordable pricing. Euvichol-Plus® is in disposable plastic tubes designed foreasier storage, transportation and wastage management. Administration is much easier than Euvichol® in glass vial presentation. EuBiologics is the largest supplier of oral cholera vaccine in the world, representing more than 80% market share and able to produce up to 50 million doses after expansion is completed in2023.
Product Name Euvichol-Plus
Product Purpose For prescription only (Export only licensure from Ministry of Food and Drug Safety in South Korea)
Administration Two doses in two weeks interval
Appearance Yellow to yellowish liquid
Efficacy / Effectiveness Prevention of cholera in all age groups of 1 year and older
Download Product Overview

Product Components

Vaccine strain Quantity
V. cholerae O1 Inaba Cairo 48 (H) 300 L.E.U*
V. cholerae O1 Inaba Phil 6973 El Tor (F) 600 L.E.U
V. cholerae O1 Ogawa Cairo 50 (F) 300 L.E.U
V. cholerae O1 Ogawa Cairo 50(H) 300 L.E.U
V. cholerae O139 4260B (F) 600 L.E.U

H:Heat inactivated F:Formalin inactivated

* LEU : Lipopolysaccharide ELISA Units

Product Information

Usage/Capacity To save Validity Features
Administer twice every two weeks Store at a temperature between 2℃ and 8℃ 24 months from manufacturing date Plastic tube presentation (Durable, light plastic tube / No buffer required)